Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator to Improve Parenchymal Clearance in Intracerebral Hemorrhage

NCT07411079 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT07411079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07411079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator to Improve Parenchymal Clearance in Intracerebral Hemorrhage
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Recruiting
Start date
March 2, 2026
Completion date
March 31, 2029
Enrollment
1,126 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding disorders, hemorrhagic risk conditions, intracerebral hemorrhage